BMJ3 天
POS0266 CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA ...
26 University of Modena and Reggio Emilia, Rheumatology Unit, Modena, Italy 27 University of Modena and Reggio Emilia, Rheumatology Unit, Modena, Italy 28 University Hospital of Parma, Internal ...
BMJ3 天
Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren’s syndrome shared ...
Objectives Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and primary Sjögren’s syndrome (pSS) share many clinical manifestations and serological features. The aim of this study was to ...
BMJ3 天
The relative contribution of mechanical stress and systemic processes in different types of ...
Correspondence to A Willemien Visser, Department of Rheumatology, Leiden University Medical Center, C1-R, P.O. Box 9600, Leiden 2300 RC, The Netherlands; a.w.visser{at}lumc.nl Objective To study the ...
BMJ3 天
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in ...
Objective: To evaluate the two generations of anti-cyclic citrullinated protein (CCP) antibodies as a diagnostic marker of rheumatoid arthritis (RA) and as a predictor of future development of RA in ...
BMJ3 天
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with ...
Correspondence to Professor Gabriela Riemekasten, Department of Rheumatology, University Hospital Schleswig-Holstein—Campus Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany; ...
BMJ3 天
Damage in the anca-associated vasculitides: long-term data from the European Vasculitis ...
Objectives To describe short-term (up to 12 months) and long-term (up to 7 years) damage in patients with newly diagnosed antineutrophil-cytoplasm antibody-associated vasculitis (AAV). Methods Data ...
BMJ3 天
Early mortality in systemic vasculitis: relative contribution of adverse events and active ...
1 Renal Institute of Birmingham, School of Infection, Immunity and Inflammation, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK Objective To contrast the effect of ...
BMJ3 天
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient ...
1 Center of Clinical Epidemiology, Hôpital Hotel Dieu; INSERM U738, Université Paris-René Descartes, Paris, France Objectives To validate the two recently developed disease activity indexes for ...
BMJ3 天
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and ...
Objective To evaluate the effectiveness and safety of secukinumab in patients with a mucosal and articular Behçet’s phenotype resistant to conventional and biologic treatment. Methods A multicentre ...
BMJ3 天
Type I interferons are involved in the development of ultraviolet B-induced inflammatory ...
Departments of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands Esther Reefman, Dept. of Rheumatology and Clinical Immunology ...
BMJ3 天
Dynamic load at baseline can predict radiographic disease progression in medial compartment ...
Correspondence to: Dr M Wada, Division of Rehabilitation Medicine, Fukui Medical University, Shimoaizuki 23, Matsuoka-cho, 910–1193, Fukui, Japan; mwada{at}do.mitene.ac.jp Objective: To test the ...
BMJ4 天
Intra-articular hyaluronan treatment for osteoarthritis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...